Study on feasibility of changing to cyclosporine from tacrolimus for better glycemic control in liver transplant recepients

被引：0
|
作者：
Raghuram, C. [1 ]
Aggarwal, S. [2 ]
Naganathan, S. K. [2 ]
Kandagaddala, R. [2 ]
Gupta, S. [2 ]
机构：
[1] Max Super Special Hosp, New Delhi, India
[2] Max Super Special Hosp, Ctr Liver & Biliary Sci, New Delhi, India
来源：
TRANSPLANTATION | 2019年 / 103卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-423
引用
收藏
页码：303 / 303
页数：1
相关论文
共 50 条
  • [21] Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients
    Fukudo, M
    Yano, I
    Masuda, S
    Fukatsu, S
    Katsura, T
    Ogura, Y
    Oike, F
    Takada, Y
    Tanaka, K
    Inui, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (02) : 168 - 181
  • [22] Safety Profile of Concomitant Use of Caspofungin and Cyclosporine or Tacrolimus in Liver Transplant Patients
    F. Saner
    J. Gensicke
    P. Rath
    N. Fruhauf
    Y. Gu
    A. Paul
    A. Radtke
    M. Malagó
    C. Broelsch
    Infection, 2006, 34 : 328 - 332
  • [23] PROGRESSION OF FIBROSIS IN HCV plus LIVER TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE OR TACROLIMUS
    Nevens, Frederik
    Klintmalm, Goran
    Villamil, Federico G.
    Jones, Robert
    Clavien, Pierre-Alain
    Metselaar, Herold J.
    Prestele, Hans
    Orsenigo, Roberto
    Levy, Gary
    TRANSPLANT INTERNATIONAL, 2013, 26 : 146 - 146
  • [24] Tacrolimus rescue in liver transplant patients with refractory rejection or intolerance or malabsorption of cyclosporine
    Klein, A
    LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (06): : 502 - 508
  • [25] Safety profile of concomitant use of caspofungin and cyclosporine or tacrolimus in liver transplant patients
    Saner, F.
    Gensicke, J.
    Rath, P.
    Fruhauf, N.
    Gu, Y.
    Paul, A.
    Radtke, A.
    Malago, M.
    Broelsch, C.
    INFECTION, 2006, 34 (06) : 328 - 332
  • [26] Sustained Virological Response With Cyclosporine and Tacrolimus in Maintenance Liver Transplant Recipients With Recurrent Hepatitis C: Results From the SUSTAIN Study
    Firpi, R.
    Duvoux, C.
    Villamil, F.
    Levy, G.
    Renner, E.
    Grazi, G.
    Schirm, F.
    Rauer, B.
    Bernhardt, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 708 - 709
  • [27] Switch of immunosuppressant therapy from tacrolimus to cyclosporine in 30 liver transplant patients who developed hyperbilirubinemia
    Wang, Lu
    Zang, Yunjin
    Lin, Dongdong
    Lu, Shichun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (08): : 12918 - 12924
  • [28] Conversion from Tacrolimus to Cyclosporine A following primary liver transplantation under Tacrolimus
    Doria, C
    Jain, A
    Marino, IR
    Gruttadauria, S
    Scott, VL
    Fung, JJ
    TRANSPLANTATION, 1999, 67 (07) : S32 - S32
  • [29] Pharmacodynamic study of tacrolimus in liver transplant patients
    Daldoul, M.
    Charfi, R.
    Ben Sassi, M.
    Ben Belgacem, M.
    Ben Hammamia, S.
    Gaies, E.
    Trabelsi, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 199 - 199
  • [30] A Retrospective Study to Compare the use of Tacrolimus and Cyclosporine in Combination with Adriamycin in Post-Transplant Liver Cancer Patients
    Gu, Liangfeng
    Jin, Wei
    Kan, Liandi
    Wang, Xia
    Shan, Chunlei
    Fan, Hui
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 71 (02) : 565 - 570
12345